REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC Amendment
03/03/2021 17:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210303:nBwZ4RsVa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC Amendment
Ap19
FORM 8.3 Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 01 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,901,431 1.47% 382,827 0.30%
(2) Derivatives (other than options):
153,127 0.12% 91,278 0.07%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
2,060,658 1.60% 480,205 0.37%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 222.1300 USD
Purchase 1 224.1700 USD
Purchase 1 224.4900 USD
Purchase 2 225.9650 USD
Purchase 7 225.8714 USD
Purchase 30 221.8200 USD
Purchase 40 224.1000 USD
Purchase 56 224.0846 USD
Purchase 100 226.3980 USD
Purchase 122 222.5389 USD
Purchase 172 227.7807 USD
Purchase 172 227.7806 USD
Purchase 173 224.1541 USD
Purchase 180 222.1000 USD
Purchase 200 226.6625 USD
Purchase 201 226.4689 USD
Purchase 299 224.0917 USD
Purchase 400 224.0150 USD
Purchase 402 226.6028 USD
Purchase 445 226.7206 USD
Purchase 495 225.0341 USD
Purchase 790 226.8703 USD
Purchase 1,147 224.6334 USD
Purchase 1,474 225.1842 USD
Purchase 3,051 226.3455 USD
Purchase 5,968 226.3724 USD
Purchase 6,348 226.7200 USD
Purchase 8,257 224.4342 USD
Purchase 16,105 224.8730 USD
Purchase 38,090 224.1256 USD
Sale 1 222.3100 USD
Sale 10 226.9600 USD
Sale 10 226.8695 USD
Sale 15 226.5323 USD
Sale 15 226.4400 USD
Sale 15 226.5033 USD
Sale 17 225.8141 USD
Sale 20 226.3097 USD
Sale 25 226.5700 USD
Sale 92 224.4873 USD
Sale 100 227.4700 USD
Sale 100 227.4000 USD
Sale 100 227.0600 USD
Sale 100 227.0500 USD
Sale 135 222.9429 USD
Sale 154 222.4963 USD
Sale 160 222.3878 USD
Sale 200 225.0325 USD
Sale 210 224.3618 USD
Sale 270 224.1317 USD
Sale 296 223.8238 USD
Sale 329 223.8169 USD
Sale 338 223.7812 USD
Sale 339 227.5095 USD
Sale 344 227.7806 USD
Sale 345 224.4782 USD
Sale 359 226.9023 USD
Sale 380 222.1000 USD
Sale 448 223.6999 USD
Sale 456 226.6893 USD
Sale 532 226.0330 USD
Sale 590 226.6789 USD
Sale 834 225.2979 USD
Sale 941 225.2920 USD
Sale 1,385 224.0722 USD
Sale 1,459 224.6537 USD
Sale 1,673 223.3168 USD
Sale 3,038 226.3439 USD
Sale 4,485 226.7200 USD
Sale 4,707 226.4442 USD
Sale 5,263 222.6836 USD
Sale 5,828 224.1511 USD
Sale 6,482 224.1985 USD
Sale 6,685 224.7145 USD
Sale 8,213 223.6457 USD
Sale 12,368 225.8824 USD
Sale 12,988 224.3219 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 3 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210303005794/en/
(https://www.businesswire.com/news/home/20210303005794/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
Announcement